Edge Wealth Management’s TG Therapeutics TGTX Stock Holding History

Edge Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+5,000	New	+$205K	0.05%	68
2025 Q4	–	Sell	-20,000	Closed	-$723K	–	93
2025 Q3	$723K	Buy	20,000 +5,000	+33%	+$165K	0.13%	43
2025 Q2	$539K	Hold	15,000	–	–	0.1%	47
2025 Q1	$591K	Hold	15,000	–	–	0.12%	44
2024 Q4	$452K	Hold	15,000	–	–	0.09%	48
2024 Q3	$351K	Hold	15,000	–	–	0.07%	58
2024 Q2	$267K	Hold	15,000	–	–	0.06%	63
2024 Q1	$228K	Hold	15,000	–	–	0.05%	67
2023 Q4	$256K	Hold	15,000	–	–	0.06%	64
2023 Q3	$125K	Hold	15,000	–	–	0.03%	74
2023 Q2	$373K	Hold	15,000	–	–	0.08%	56
2023 Q1	$224K	Hold	15,000	–	–	0.05%	62
2022 Q4	$171K	Hold	15,000	–	–	0.04%	76
2022 Q3	$92K	Hold	15,000	–	–	0.02%	77
2022 Q2	$64K	Hold	15,000	–	–	0.01%	85
2022 Q1	$143K	Hold	15,000	–	–	0.03%	85
2021 Q4	$285K	Hold	15,000	–	–	0.05%	83
2021 Q3	$499K	Hold	15,000	–	–	0.1%	66
2021 Q2	$586K	Buy	15,000 +5,000	+50%	+$196K	0.12%	63
2021 Q1	$482K	Sell	10,000 -21,420	-68%	-$1.03M	0.1%	68
2020 Q4	$1.64M	Sell	31,420 -2,500	-7%	-$84.5K	0.37%	49
2020 Q3	$908K	Buy	33,920 +1,000	+3%	+$23K	0.21%	57
2020 Q2	$641K	Buy	32,920 +1,500	+5%	+$24.2K	0.12%	85
2020 Q1	$311K	Hold	31,420	–	–	0.07%	113
2019 Q4	$354K	Hold	31,420	–	–	0.07%	114
2019 Q3	$176K	Hold	31,420	–	–	0.04%	143
2019 Q2	$270K	Buy	+31,420	New	+$238K	0.06%	121

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Edge Wealth Management's TGTX Position: Q2 2026 in Review

Edge Wealth Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 5,000 shares worth $275K. The stake represents 0.05% of the portfolio and ranks #68 among its holdings. This is a return to the name: Edge Wealth Management previously reported a position in TGTX as recently as Q3 2025.

Edge Wealth Management first reported a position in TGTX in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.64M in Q4 2020. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Edge Wealth Management held 5,000 shares of TG Therapeutics worth $275K as of Q2 2026.
TG Therapeutics was a new Edge Wealth Management position in Q2 2026.
TG Therapeutics made up 0.05% of Edge Wealth Management's portfolio in Q2 2026, its #68 holding.
Edge Wealth Management first reported a position in TG Therapeutics in Q2 2019 and has held it in 27 quarters since.
Edge Wealth Management's TG Therapeutics position peaked at $1.64M in Q4 2020.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Edge Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.